Skip to main content

Thermo Fisher Scientific cash flow statement

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

In fiscal 2025 (the year to 31 Dec 2025), Thermo Fisher Scientific generated $7.82B of operating cash flow and $6.29B of free cash flow, after $1.52B of capital expenditure.

From Thermo Fisher Scientific's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Thermo Fisher Scientific cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$748.4M$980.9M$850.3M$1.04B$1.33B$1.18B$1.27B$1.89B$1.98B$2.02B$2.23B$2.94B$3.70B$6.38B$7.72B$6.95B$6.00B$6.33B$6.70B$7.07B
Depreciation & amortization$756.8M$792.7M$762.9M$739.7M$859.6M$983.7M$999.9M$1.68B$1.69B$1.76B$2.03B$2.27B$2.28B$2.33B$2.59B$3.38B$3.41B$3.11B$2.78B$3.11B
Stock-based compensation$51.10M$57.10M$67.00M$81.60M$80.00M$78.20M$90.90M$117.1M$125.0M$133.0M$159.0M$181.0M$181.0M$196.0M$230.0M$307.0M$278.0M$301.0M$310.0M$345.0M
Operating cash flow$1.48B$1.42B$1.66B$1.50B$1.69B$2.04B$2.01B$2.62B$2.94B$3.26B$4.00B$4.54B$4.97B$8.29B$9.31B$9.15B$8.41B$8.67B$7.82B$9.32B
Operating cash flow margin15.2%13.5%16.7%14.4%14.6%16.3%15.4%15.5%17.3%17.8%19.1%18.7%19.5%25.7%23.7%20.4%19.6%20.2%17.5%19.7%
Capital expenditures$175.5M$264.4M$200.0M$245.4M$260.9M$315.1M$282.4M$427.6M$423.0M$444.0M$508.0M$758.0M$926.0M$1.47B$2.52B$2.24B$1.48B$1.40B$1.52B$1.73B
Acquisitions$492.5M$201.5M$637.3M$606.2M$5.69B$1.08B$11.40M$13.06B$695.0M$5.18B$7.23B$536.0M$1.84B$38.00M$19.39B$39.00M$3.66B$3.13B$4.04B$8.88B
Free cash flow$1.31B$1.16B$1.46B$1.25B$1.43B$1.72B$1.73B$2.19B$2.52B$2.81B$3.50B$3.79B$4.05B$6.82B$6.79B$6.91B$6.93B$7.27B$6.29B$7.60B
Free cash flow margin13.4%11.0%14.7%12.1%12.4%13.8%13.2%13.0%14.8%15.4%16.7%15.5%15.8%21.2%17.3%15.4%16.2%16.9%14.1%16.0%
Free cash flow per share$2.95$2.66$3.45$3.06$3.72$4.70$4.72$5.45$6.27$7.09$8.79$9.32$10.04$17.08$17.10$17.54$17.85$18.97$16.65$20.37
Dividends paid————$0.00$142.2M$216.2M$234.8M$241.0M$238.0M$237.0M$266.0M$297.0M$337.0M$395.0M$455.0M$523.0M$583.0M$636.0M$673.0M
Gross share repurchases$898.0M$187.4M$414.6M$1.01B$1.34B$1.15B$89.80M$0.00$500.0M$1.25B$750.0M$500.0M$1.50B$1.50B$2.00B$3.00B$3.00B$4.00B$3.00B$4.04B
Stock issuance proceeds$345.4M$85.10M$54.40M$77.30M$158.1M$254.1M$230.4M$155.4M$72.00M$87.00M$128.0M$136.0M$153.0M$196.0M$156.0M—————
Net share repurchases$552.6M$102.3M$360.2M$935.2M$1.18B$895.9M−$140.6M−$155.4M$428.0M$1.16B$622.0M$364.0M$1.35B$1.30B$1.84B$3.00B$3.00B$4.00B$3.00B$4.04B
Cash interest paid—$129.5M$99.60M$82.50M$120.6M$230.0M$215.1M$435.9M$438.0M$458.0M$533.0M$687.0M$790.0M$471.0M$555.0M$667.0M$1.39B$1.57B$1.61B—
Free cash flow after SBC$1.26B$1.10B$1.39B$1.17B$1.35B$1.65B$1.64B$2.07B$2.39B$2.68B$3.34B$3.60B$3.87B$6.62B$6.56B$6.60B$6.65B$6.97B$5.98B$7.25B

Quarterly

Thermo Fisher Scientific cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$1.63B$1.33B$1.55B$1.63B$1.83B$1.51B$1.62B$1.62B$1.96B$1.65B$1.74B$1.72B
Depreciation & amortization$839.0M$836.0M$791.0M$739.0M$742.0M$705.0M$686.0M$661.0M$728.0M$736.0M$817.0M$825.0M
Stock-based compensation$61.00M$70.00M$84.00M$68.00M$79.00M$75.00M$81.00M$70.00M$84.00M$83.00M$82.00M$96.00M
Operating cash flow$3.72B$1.25B$1.96B$2.17B$3.29B$723.0M$1.40B$2.24B$3.46B$1.19B$2.13B$2.55B
Operating cash flow margin34.2%12.1%18.6%20.4%28.9%7.0%12.9%20.1%28.3%10.8%17.7%21.0%
Capital expenditures$405.0M$347.0M$301.0M$272.0M$480.0M$362.0M$294.0M$404.0M$465.0M$376.0M$450.0M$437.0M
Acquisitions$0.00$0.00$0.00$3.13B$0.00$0.00$0.00$4.04B$0.00$8.87B$0.00$5.00M
Free cash flow$3.32B$904.0M$1.66B$1.89B$2.81B$361.0M$1.10B$1.83B$2.99B$816.0M$1.68B$2.11B
Free cash flow margin30.5%8.7%15.7%17.9%24.7%3.5%10.2%16.5%24.5%7.4%14.0%17.4%
Free cash flow per share$8.55$2.35$4.33$4.93$7.34$0.95$2.92$4.85$7.94$2.19$4.51$5.70
Dividends paid$136.0M$135.0M$149.0M$150.0M$149.0M$149.0M$162.0M$163.0M$162.0M$162.0M$175.0M$174.0M
Gross share repurchases$0.00$3.00B$0.00$0.00$1.00B$2.00B$0.00$963.0M$37.00M$3.00B$1.00B$0.00
Net share repurchases$0.00$3.00B$0.00$0.00$1.00B$2.00B$0.00$963.0M$37.00M$3.00B$1.00B$0.00
Free cash flow after SBC$3.26B$834.0M$1.57B$1.83B$2.73B$286.0M$1.02B$1.76B$2.91B$733.0M$1.59B$2.02B

The main figures as JSON and plain text. See data and methodology.

TMO in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.